|
Delayed
Bombay S.E.
04:30:05 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 1,658.95 INR | +1.33% |
|
+6.58% | +112.96% |
| 08-09 | Indian shares set to gain as soft US jobs data offsets oil worries | RE |
| 08-07 | Novartis India Limited Terminates Distribution and Promotion Agreement with Dr. Reddy?S Laboratories Limited | CI |
| Market Cap | 40.42B 428M 368M 347M 317M 592M 594M 4.1B 1.59B 20.74B 1.61B 1.57B 66.81B | P/E 2025 |
19.2x | P/E 2026 | 25.7x |
|---|---|---|---|---|---|
| Enterprise Value | 33.88B 359M 309M 291M 265M 496M 498M 3.43B 1.33B 17.38B 1.35B 1.32B 56B | EV / Sales 2025 |
3.67x | EV / Sales 2026 | 4.92x |
| Free-Float |
41.32% | Yield 2025 |
3.18% | Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| NOVARTIND | Delayed | |
NSE India S.E.
| NOVARTIND | Delayed |
| 1 day | +1.33% | ||
| 1 week | +6.58% | ||
| Current month | +6.58% | ||
| 1 month | +3.05% | ||
| 3 months | +22.49% | ||
| 6 months | +76.72% | ||
| Current year | +112.96% |
| 1 week | 1,530.35 |  | 1,696.9 |
| 1 month | 1,387 | | 1,696.9 |
| Current year | 750 | | 1,777.5 |
| 1 year | 750 | | 1,777.5 |
| 3 years | 599.95 | | 1,777.5 |
| 5 years | 554 | | 1,777.5 |
| 10 years | 420.05 | | 1,777.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 2026-07-29 |
Chandni Maru
CMP | Compliance Officer | - | 2024-05-07 |
Amitabh Dube
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ashok Bhatia
BRD | Director/Board Member | 72 | 2026-07-28 |
| Director/Board Member | - | 2026-07-28 | |
Jagriti Gupta
BRD | Director/Board Member | - | 2026-07-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.33% | +6.58% | +79.57% | +127.19% | 428M | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| -1.50% | -0.40% | +30.10% | +36.92% | 352B | |
| -3.61% | +1.48% | +22.24% | +41.13% | 304B | |
| +0.64% | +0.95% | +0.89% | +11.57% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| -0.56% | +1.61% | -14.37% | -56.07% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -0.88% | +2.15% | +33.68% | +59.53% | 367.88B | |
| Weighted average by Cap. | -1.16% | +0.62% | +37.55% | +66.80% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.56B 37.73M 32.47M 30.55M 27.91M 52.21M 52.35M 361M 140M 1.83B 142M 139M 5.89B | 3.54B 37.53M 32.29M 30.38M 27.76M 51.92M 52.06M 359M 139M 1.82B 141M 138M 5.86B |
| Net income | 1.01B 10.69M 9.2M 8.65M 7.9M 14.79M 14.83M 102M 39.67M 518M 40.13M 39.25M 1.67B | 932M 9.87M 8.49M 7.99M 7.3M 13.65M 13.69M 94.42M 36.64M 478M 37.06M 36.25M 1.54B |
| Net Debt | -6.32B -66.94M -57.6M -54.19M -49.51M -92.61M -92.86M -640M -249M -3.24B -251M -246M -10.45B | -6.54B -69.3M -59.63M -56.11M -51.25M -95.88M -96.14M -663M -257M -3.36B -260M -255M -10.81B |
Employees
57
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | ₹1,658.95 | +1.33% | 141,260 |
| 26-09-04 | ₹1,637.10 | +1.37% | 2,002 |
| 26-09-03 | ₹1,614.95 | +0.80% | 803 |
| 26-09-02 | ₹1,602.15 | +1.11% | 1,101 |
| 26-09-01 | ₹1,584.60 | +1.81% | 1,963 |
- Stock Market
- Stocks
- NOVARTIND Stock
Select your edition
All financial news and data tailored to specific country editions
